Ivania Rizo, MD is equally passionate about diabetes, obesity, and health equity. She is Director of Obesity Medicine at BMC and Assistant Professor of Medicine in Endocrinology, Diabetes, Nutrition, and Weight Management at the Chobanian and Avedisian School of Medicine. She attended Georgetown University Medical School and Internal Medicine residency at Georgetown University. After completing her Endocrinology fellowship at the University of Alabama, Birmingham, she worked there as an Assistant Professor and as a Staff Physician at the Kirkland Medical Clinic before being appointed to her current position. She is triple board certified in Internal Medicine, Endocrinology, and Obesity Medicine. She currently Director of Obesity Medicine at BMC with a clinical interest in obesity , diabetes and metabolic disorders. She is passionate about increasing equitable access to diabetes and obesity care and providing exceptional care without exception. Dr. Rizo is a member of the following medical societies: the Endocrine Society, the American Diabetes Association, and the Obesity Society.
Diversity, Equity, Inclusion and Accessibility
As a Spanish speaking first generation immigrant from Nicaragua, Dr. Rizo is committed to including racial justice and advancing health equity in medical care, specifically in diabetes and obesity. Diabetes and obesity impacts racially and ethnically diverse communities at higher rates. It is Dr. Rizo’s goal to decrease the racial disparities in the community we serve at BMC. Dr. Rizo is doing research looking at social determinants of health ( SDOH) and its impact on weight regain in post bariatric surgery patients at BMC. By including SDOH in her work, she hopes to decrease the barriers to care and ultimately improve the care we provide to our diverse community.
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
to make corrections and additions.
Ryan TJ, Heyman AS, Mulvey EN, McLaughlin A, Rizo IM, Assoumou SA. Factors associated with inpatient complications among patients with obesity and COVID-19 at an urban safety-net hospital: A retrospective cohort study. Obes Sci Pract. 2022 Aug 15; 8(6):794-800.View Related Profiles. PMID: 35938065; PMCID: PMC9347368; DOI: 10.1002/osp4.623;
Nolen-Doerr E, Stockman MC, Rizo I. Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity. Curr Obes Rep. 2019 Sep; 8(3):284-291.View Related Profiles. PMID: 31124035
Dupepe E, Patel D, Miller J, Rizo I, Vaughan TB, Riley K. Postoperative day 1 versus postoperative day 5 morning cortisol for predicting an intact hypothalamic-pituitary axis: A cohort analysis. Surg Neurol Int. 2019; 10:91. PMID: 31528429; PMCID: PMC6744762; DOI: 10.25259/SNI-105-2019;
Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity. J Diabetes Sci Technol. 2018 11; 12(6):1239-1240.View Related Profiles. PMID: 29957042; PMCID: PMC6232739; DOI: 10.1177/1932296818784068;
Hotez PJ, Ashcom J, Bin Z, Bethony J, Williamson A, Hawdon JM, Jianjun F, Dobardzic A, Rizo I, Bolden J, Jin Q, Yan W, Dobardzic R, Chung-Debose S, Crowell M, Datu B, Delaney A, Dragonovski D, Jiang Y, Yueyuan L, Ghosh K, Loukas A, Brandt W, Russell PK, Zook BC. Effect of vaccinations with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. J Parasitol. 2002 Aug; 88(4):684-90. PMID: 12197114
Mantey SA, Coy DH, Pradhan TK, Igarashi H, Rizo IM, Shen L, Hou W, Hocart SJ, Jensen RT. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3. J Biol Chem. 2001 Mar 23; 276(12):9219-29. PMID: 11112777
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.